Actelion Pharmaceuticals UK Ltd

BSI Building 13th Floor, 389 Chiswick High Road, Chiswick, London, W4 4AL
Telephone: +44 (0)208 987 3333
Fax: +44 (0)208 987 3322
WWW: http://www.actelion.com
Medical Information Direct Line: +44 (0)845 075 0555 (UK) / +353 (0)1 890 771 648

Patient Information Leaflet last updated on the eMC: 09/01/2012
PIL Tracleer (bosentan) 62.5mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
Updated on 08/03/2011 and displayed until 09/01/2012
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/05/2010 and displayed until 08/03/2011
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 29/01/2010 and displayed until 07/05/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 10/12/2009 and displayed until 29/01/2010
Reasons for adding or updating:
  • Change of contra-indications
Updated on 26/08/2008 and displayed until 10/12/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 19/08/2008 and displayed until 26/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 03/01/2008 and displayed until 19/08/2008
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 27/11/2007 and displayed until 03/01/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   bosentan monohydrate